{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:53:29Z","timestamp":1793710409917,"version":"4.6.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02577-9","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T03:05:13Z","timestamp":1748228713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical features and outcomes of newly diagnosed classical Hodgkin lymphoma patients in Saudi Arabia: a multicenter cohort study"],"prefix":"10.1038","volume":"15","author":[{"given":"Mai","family":"Alalawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M.","family":"Alrajhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa A.","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal H.","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Alhaj Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej","family":"Abumostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Alhaj Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashayer","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadah","family":"Alyousif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Alkhudair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Alsuhebany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrar","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hessah","family":"Alrashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batoul A.","family":"Alenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaden H.","family":"Alonazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer A.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Asiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer A.","family":"Alenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moureq","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Aldebasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Al Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"2577_CR1","unstructured":"Stein, H. et al. In WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. (eds Swerdlow, S. H. et al.) 423\u2013442 (International Agency for Research on Cancer, 2017)."},{"key":"2577_CR2","doi-asserted-by":"publisher","unstructured":"Alaggio, R., Amador, C., Anagnostopoulos, I. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36, 1720\u20131748. https:\/\/doi.org\/10.1038\/s41375-022-01620-2 (2022).","DOI":"10.1038\/s41375-022-01620-2"},{"key":"2577_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41572-020-0189-6","volume":"6","author":"JM Connors","year":"2020","unstructured":"Connors, J. M. et al. Hodgkin lymphoma. Nat. Rev. Dis. Primers 6, 61. https:\/\/doi.org\/10.1038\/s41572-020-0189-6 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2577_CR4","unstructured":"The International Agency for Research on Cancer (IARC). Global cancer observatory. Global Cancer Observatory (accessed 2 Nov 2022)."},{"key":"2577_CR5","unstructured":"Saudi Health Council. Cancer Incidence Report 2020 [PDF]. https:\/\/shc.gov.sa\/Arabic\/NCC\/Activities\/AnnualReports\/Cancer%20Incidence%20Report%202020.pdf (2020)."},{"key":"2577_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000460819","volume":"40","author":"RG Shafi","year":"2017","unstructured":"Shafi, R. G. et al. Hodgkin lymphoma outcome: a retrospective study from 3 tertiary centers in Saudi Arabia. Oncol. Res. Treat. 40, 288\u2013292 (2017).","journal-title":"Oncol. Res. Treat."},{"issue":"6","key":"2577_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/ijc.2910470605","volume":"47","author":"HY Al-Idrissi","year":"1991","unstructured":"Al-Idrissi, H. Y. & Ibrahim, E. M. Hodgkin\u2019s disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only, for both localized and advanced disease. Int. J. Cancer 47(6), 822\u2013826. https:\/\/doi.org\/10.1002\/ijc.2910470605 (1991).","journal-title":"Int. J. Cancer"},{"key":"2577_CR8","unstructured":"SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute. https:\/\/seer.cancer.gov\/explorer\/ (accessed 23 Feb 2023)."},{"key":"2577_CR9","unstructured":"National Comprehensive Cancer Network. Hodgkin Lymphoma (Version 1.2025). (2025). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hodgkins.pdf"},{"key":"2577_CR10","unstructured":"Saudi Health Council. Cancer Incidence Report Saudi Arabia. Annual report 2018. https:\/\/shc.gov.sa\/Arabic\/NCC\/Activities\/AnnualReports\/2018.pdf (accessed 4 Oct 2023)."},{"key":"2577_CR11","unstructured":"Kaseb, H., Babiker, H. M. Hodgkin lymphoma. [Updated 2023 Jun 26]. In StatPearls. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK499969\/ (StatPearls Publishing, 2023)."},{"key":"2577_CR12","unstructured":"Saudi Population by Gender, Age Groups and Nationality (Saudi\/Non-Saudi). General Authority for Statistics. https:\/\/www.stats.gov.sa\/en\/5680 (accessed 5 Oct 2023)."},{"issue":"21","key":"2577_CR13","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.1158\/1078-0432.CCR-06-1420","volume":"12","author":"E Brusamolino","year":"2006","unstructured":"Brusamolino, E. et al. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin\u2019s lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up. Clin. Cancer Res. 12(21), 6487\u20136493. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-1420 (2006).","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"2577_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3349\/ymj.2006.47.4.455","volume":"47","author":"JW Cheong","year":"2006","unstructured":"Cheong, J. W., Park, S. Y., Roh, J. K., Suh, C. O. & Hahn, J. S. Treatment of Hodgkin\u2019s disease: a twenty-year follow-up of patients at a center in Korea. Yonsei Med. J. 47(4), 455\u2013465. https:\/\/doi.org\/10.3349\/ymj.2006.47.4.455 (2006).","journal-title":"Yonsei Med. J."},{"issue":"5","key":"2577_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.clml.2017.02.005","volume":"17","author":"WY Yu","year":"2017","unstructured":"Yu, W. Y. et al. Clinical features and prognosis analysis of Hodgkin lymphoma: a multicenter retrospective study over a decade of patients in China. Clin. Lymphoma Myeloma Leuk. 17(5), 274\u2013282. https:\/\/doi.org\/10.1016\/j.clml.2017.02.005 (2017).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"8","key":"2577_CR16","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1093\/annonc\/mdr578","volume":"23","author":"AM Evens","year":"2012","unstructured":"Evens, A. M., Antill\u00f3n, M., Aschebrook-Kilfoy, B. & Chiu, B. C. Racial disparities in Hodgkin\u2019s lymphoma: a comprehensive population-based analysis. Ann. Oncol. 23(8), 2128\u20132137. https:\/\/doi.org\/10.1093\/annonc\/mdr578 (2012).","journal-title":"Ann. Oncol."},{"key":"2577_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/1097-0142(20010715)92:2<218::AID-CNCR1312>3.0.CO;2-6","volume":"92","author":"SL Glaser","year":"2001","unstructured":"Glaser, S. L., Dorfman, R. F. & Clarke, C. A. Expert review of the diagnosis and histologic classification of Hodgkin disease in a population-based cancer registry. Cancer 92, 218\u2013224. https:\/\/doi.org\/10.1002\/1097-0142(20010715)92:2%3c218::AID-CNCR1312%3e3.0.CO;2-6 (2001).","journal-title":"Cancer"},{"issue":"17","key":"2577_CR18","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1056\/NEJMoa1408648","volume":"372","author":"J Radford","year":"2015","unstructured":"Radford, J. et al. Results of a trial of PET-directed therapy for early-stage Hodgkin\u2019s lymphoma. N. Engl. J. Med. 372(17), 1598\u20131607. https:\/\/doi.org\/10.1056\/NEJMoa1408648 (2015).","journal-title":"N. Engl. J. Med."},{"issue":"31","key":"2577_CR19","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1200\/JCO.19.00964","volume":"37","author":"M Fuchs","year":"2019","unstructured":"Fuchs, M. et al. Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: Final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group. J. Clin. Oncol. 37(31), 2835\u20132845. https:\/\/doi.org\/10.1200\/JCO.19.00964 (2019).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"2577_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41375-023-02064-y","volume":"38","author":"M Fuchs","year":"2024","unstructured":"Fuchs, M. et al. Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma. Leukemia 38(1), 160\u2013167. https:\/\/doi.org\/10.1038\/s41375-023-02064-y (2024).","journal-title":"Leukemia"},{"issue":"1","key":"2577_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1200\/JCO.23.01745","volume":"42","author":"M Federico","year":"2024","unstructured":"Federico, M. et al. Long-term follow-up of the response-adapted intergroup EORTC\/LYSA\/FIL H10 trial for localized hodgkin lymphoma. J. Clin. Oncol. 42(1), 19\u201325. https:\/\/doi.org\/10.1200\/JCO.23.01745 (2024).","journal-title":"J. Clin. Oncol."},{"key":"2577_CR22","unstructured":"BLENOXANE (Bleomycin) [prescribing information].Princeton, NJ, USA; Bristol-Myers Squibb Company. April (2010)"},{"key":"2577_CR23","doi-asserted-by":"publisher","unstructured":"Tayshetye P, et al. Bleomycin-induced pulmonary toxicity: A retrospective review of incidence and risk factors. J. Clin. Oncol. https:\/\/doi.org\/10.1200\/JCO.2018.36.15_suppl.e16532.","DOI":"10.1200\/JCO.2018.36.15_suppl.e16532"},{"issue":"Suppl 1","key":"2577_CR24","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1038\/bmt.2008.111","volume":"42","author":"S Akhtar","year":"2008","unstructured":"Akhtar, S. et al. High-dose chemotherapy and autologous stem cell transplantation for Hodgkin\u2019s lymphoma in the Kingdom of Saudi Arabia: King Faisal Specialist Hospital and Research Center experience. Bone Marrow Transplant. 42(Suppl 1), S37\u2013S40. https:\/\/doi.org\/10.1038\/bmt.2008.111 (2008).","journal-title":"Bone Marrow Transplant."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02577-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02577-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02577-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T03:05:21Z","timestamp":1748228721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02577-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2577"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02577-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4547516\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of King Abdullah International Medical Research Center (IRB-KAIMRC), Riyadh, Saudi Arabia approved the study on November 5, 2023. The study received the IRB registration number NRC23R-637-10. All methods were performed under relevant guidelines and regulations. Participants\u2019 confidentiality was strictly observed throughout the study using the anonymous unique serial number for each subject and restricting data only to the investigators. Informed consent was waived because of the study\u2019s retrospective nature by the Institutional Review Board of King Abdullah International Medical Research Center (IRB-KAIMRC), Riyadh, Saudi Arabia, and the analysis used anonymous clinical data as per the policy of the local research center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18308"}}